Natixis Advisors, L.P. Sanofi Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Sanofi stock. As of the latest transaction made, Natixis Advisors, L.P. holds 2,874,193 shares of SNY stock, worth $148 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

2,874,193

Previous 2,760,060 4.14%

Holding current value

$148 Million

Previous $134 Million 23.69%

% of portfolio

0.32%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$48.54 - $58.53 $5.54 Million - $6.68 Million	114,133 Added 4.14%	2,874,193 $166 Million
Q2 2024 Aug 01, 2024	BUY	$45.39 - $50.36 $3.26 Million - $3.61 Million	71,713 Added 2.67%	2,760,060 $134 Million
Q1 2024 Apr 25, 2024	BUY	$45.75 - $52.48 $10.2 Million - $11.7 Million	222,585 Added 9.03%	2,688,347 $131 Million
Q4 2023 Feb 06, 2024	SELL	$43.13 - $54.79 $2.7 Million - $3.43 Million	-62,527 Reduced 2.47%	2,465,762 $123 Million
Q3 2023 Nov 13, 2023	BUY	$50.95 - $55.2 $17.7 Million - $19.1 Million	346,563 Added 15.88%	2,528,289 $136 Million
Q2 2023 Aug 15, 2023	BUY	$50.45 - $57.18 $9.81 Million - $11.1 Million	194,439 Added 9.78%	2,181,726 $118 Million
Q1 2023 May 11, 2023	BUY	$45.86 - $54.45 $13.7 Million - $16.3 Million	299,652 Added 17.76%	1,987,287 $108 Million
Q4 2022 Jan 27, 2023	BUY	$38.86 - $48.55 $31.6 Million - $39.5 Million	813,365 Added 93.03%	1,687,635 $81.7 Million
Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $22.7 Million - $61.2 Million	-609,009 Reduced 41.06%	874,270 $33.2 Million
Q2 2022 Aug 12, 2022	BUY	$48.99 - $57.46 $4.36 Million - $5.12 Million	89,054 Added 6.39%	1,483,279 $74.2 Million
Q1 2022 May 12, 2022	BUY	$48.48 - $53.65 $5.59 Million - $6.19 Million	115,329 Added 9.02%	1,394,225 $71.6 Million
Q4 2021 Feb 08, 2022	BUY	$47.07 - $52.35 $4.45 Million - $4.95 Million	94,632 Added 7.99%	1,278,896 $64.1 Million
Q3 2021 Nov 15, 2021	SELL	$47.89 - $53.12 $766,623 - $850,344	-16,008 Reduced 1.33%	1,184,264 $57.1 Million
Q2 2021 Aug 12, 2021	BUY	$49.36 - $54.25 $2.85 Million - $3.13 Million	57,729 Added 5.05%	1,200,272 $63.2 Million
Q1 2021 May 05, 2021	BUY	$45.46 - $50.51 $4.98 Million - $5.53 Million	109,489 Added 10.6%	1,142,543 $56.5 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $51.62 $1.25 Million - $1.42 Million	27,513 Added 2.74%	1,033,054 $50.2 Million
Q3 2020 Nov 12, 2020	BUY	$49.47 - $53.77 $861,816 - $936,727	17,421 Added 1.76%	1,005,541 $50.4 Million
Q2 2020 Aug 11, 2020	SELL	$42.91 - $52.5 $759,378 - $929,092	-17,697 Reduced 1.76%	988,120 $50.4 Million
Q1 2020 Apr 27, 2020	BUY	$38.02 - $51.66 $4.03 Million - $5.47 Million	105,900 Added 11.77%	1,005,817 $44 Million
Q4 2019 Feb 10, 2020	BUY	$44.25 - $50.86 $8.63 Million - $9.92 Million	195,127 Added 27.69%	899,917 $45.2 Million
Q3 2019 Nov 12, 2019	BUY	$40.34 - $46.64 $5.16 Million - $5.97 Million	127,927 Added 22.18%	704,790 $32.7 Million
Q2 2019 Aug 12, 2019	BUY	$40.43 - $44.3 $5.05 Million - $5.54 Million	124,999 Added 27.66%	576,863 $25 Million
Q1 2019 May 15, 2019	BUY	$40.83 - $45.43 $6.17 Million - $6.87 Million	151,144 Added 50.26%	451,864 $20 Million
Q4 2018 Feb 13, 2019	BUY	$41.48 - $45.59 $156,628 - $172,147	3,776 Added 1.27%	300,720 $13.1 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $1.9 Million - $2.13 Million	-47,421 Reduced 13.77%	296,944 $13.3 Million
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $1.02 Million - $1.12 Million	27,078 Added 8.53%	344,365 $0
Q1 2018 May 10, 2018	SELL	$38.98 - $45.76 $638,492 - $749,548	-16,380 Reduced 4.91%	317,287 $12.7 Million
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $1.43 Million - $1.69 Million	-33,400 Reduced 9.1%	333,667 $14.3 Million
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $17.3 Million - $18.5 Million	367,067	367,067 $18.3 Million

Others Institutions Holding SNY

# of Institutions

809

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $129B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Sanofi Transaction History